cell therapy
-
An ALS Therapy Gets a Fast-Track Label — Read the Data First
The FDA granted Fast Track to an investigational Treg cell therapy for ALS, with early data showing NfL down about 60% in six patients. Cross-reference…
The FDA granted Fast Track to an investigational Treg cell therapy for ALS, with early data showing NfL down about 60% in six patients. Cross-reference…